Details of the Drug Formulations

General Information of Drug (ID: DM6NZ2P)

Drug Name
Pegvaliase Drug Info
Synonyms BMN 165; Pegvaliase [INN]; UNII-N6UAH27EUV; N6UAH27EUV
Indication
Disease Entry ICD 11 Status REF
Phenylketonuria 5C50.0 Approved [1]
Cross-matching ID
PubChem CID
86278362
CAS Number
1585984-95-7
TTD ID
D0T8HZ
ACDINA ID
D01326

Full List of Drug Formulations Containing This Drug

Pegvaliase 10mg/0.5 ml Injection
Company Formulation ID FDA Description
Biomarin Pharmaceutical F24305 Sodium Chloride; Trans-Cinnamic Acid; Tromethamine; Tromethamine Hydrochloride
------------------------------------------------------------------------------------
Pegvaliase 2.5mg/0.5 ml Injection
Company Formulation ID FDA Description
Biomarin Pharmaceutical F24352 Sodium Chloride; Trans-Cinnamic Acid; Tromethamine; Tromethamine Hydrochloride
------------------------------------------------------------------------------------
Pegvaliase 20 mg/ml Injection
Company Formulation ID FDA Description
Biomarin Pharmaceutical F24356 Sodium Chloride; Trans-Cinnamic Acid; Tromethamine; Tromethamine Hydrochloride
------------------------------------------------------------------------------------

References

1 Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.Mol Genet Metab. 2018 Nov;125(3):217-227.